Medication non-adherence means patients do not take their medicine as prescribed. This is a big problem for people with long-term illnesses. Diseases like high blood pressure, diabetes, and high cholesterol need regular medicine to keep under control. But many patients do not follow their medication plans well enough.
When patients do not stick to their medicine plans, their health can get worse. Also, this leads to more hospital visits and higher healthcare costs. For clinic managers and leaders, helping patients take their medicine properly is both important for health and for saving money.
Clinical pharmacists are medicine experts. They work with patients and doctors to make sure medicine is used the right way. Pharmacists check patients’ medications, give advice, and follow up to help patients keep taking their medicine.
Research shows that when pharmacists lead these programs, patients do better. For example, a study showed pharmacist help reduced hospital visits by 16% and readmissions by 80%. Medication adherence improved by more than 50%. This means patients followed their medicine plans much better.
Pharmacists also help improve health measures. Blood pressure control went from 55% to 70% after pharmacist support. Diabetes medicine adherence rose from 37.5% to 59.5%. These changes lower health risks and improve lives.
Pharmacists can also find when patients are taking too many medicines and adjust their plans. This helps especially older adults who can get bad side effects from too many drugs. Overall, pharmacists make medicine use safer and reduce hospital stays and costs.
Artificial Intelligence, or AI, means computer systems that can do tasks needing human thinking. In healthcare, AI can handle lots of patient data, find patterns, predict risks, and help make decisions.
When pharmacists use AI tools, they can improve medicine adherence programs. AI gives up-to-date and accurate info to help care for patients.
One large study with over 10,400 patients with high blood pressure, high cholesterol, and diabetes showed good results from using AI with pharmacists. The program, run at the Medical University of South Carolina, used AI to find 2,762 medication adherence problems.
After using AI, medicine adherence went up by 5.9% for blood pressure meds, 7.9% for cholesterol meds, and 6.4% for diabetes meds. Patients with diabetes who reached their blood sugar control goals went up from 75.5% to 81.7%. These improvements also helped raise Medicare quality ratings.
AI helped pharmacists focus on patients who needed help the most. Pharmacists then reviewed cases and reached out to patients with calls and education. This made their work more targeted and efficient.
For clinic managers and IT staff, using AI to help pharmacists is a key way to improve care and keep costs down. AI tools can automate tracking medicine use and help pharmacists work faster and better.
Using AI needs investment in tech and training. But the benefits—like a 31% cost saving for high blood pressure, 25% for cholesterol, and 32% for diabetes patients who follow medicine plans—make it worth it. AI use in medication programs is becoming needed in U.S. healthcare.
Clinic leaders focus on better care and saving money. Using pharmacists with AI insights brings benefits in health and costs.
These results show that funding pharmacist-led programs with AI brings clear returns. This fits well with U.S. health goals for better care, lower costs, and quality measurements.
Even with benefits, using AI in pharmacy services has challenges for U.S. clinics and IT teams.
By managing these issues, U.S. healthcare can make full use of AI-assisted pharmacist medication programs.
Chronic diseases in the U.S. require new ways to care for patients. Clinical pharmacists know how to manage medicines well. AI provides data-driven tools to spot and fix medicine use problems. Together, they help lower costs, improve lab results, and raise care quality.
For clinic managers, owners, and IT staff, using AI with pharmacists is a practical way to handle chronic disease care today. By using technology to automate work and focusing pharmacists on patient help, health providers can get better results for patients and clinics.
The primary objective was to evaluate the impact of a clinical pharmacist-led, AI-supported medication adherence program on medication adherence, select chronic disease control measures, and health care expenditures in patients with chronic diseases.
The program focused on medication adherence for hypertension, cholesterol management (hyperlipidemia), and diabetes, tracking respective adherence measures MAH (hypertension), MAC (cholesterol), and MAD (diabetes).
A multicenter, retrospective, quasi-experimental evaluation compared data from preimplementation (January-December 2019) and postimplementation periods (January-December 2021), assessing medication adherence, disease control, and cost savings.
The program was deployed across 10,477 patients, with 60.6% involved in at least one medication-related measure, resulting in 2762 actionable medication adherence gaps identified for intervention.
Medication adherence improved significantly: hypertension adherence by 5.9%, cholesterol adherence by 7.9%, and diabetes adherence by 6.4%, demonstrating enhanced compliance across all targeted disease states.
Yes, the percentage of patients with diabetes who achieved their A1c control goal increased from 75.5% to 81.7%, indicating better disease management linked to improved medication adherence.
Patients adherent to medications showed substantial cost savings per member per month: 31% savings for hypertension, 25% for hyperlipidemia, and 32% for diabetes, reflecting reduced health care expenditures tied to adherence.
The program combined AI-supported analytics to identify adherence gaps, enabling pharmacists to conduct individual patient case reviews and targeted outreach, thereby enhancing personalized intervention and adherence outcomes.
Clinical pharmacists led individual patient outreach and case review leveraging AI data, optimizing medication management strategies to improve adherence and chronic disease control effectively.
Medicare Star ratings improved post-program implementation, reflecting broader enhancements in patient care quality linked to increased medication adherence in chronic conditions.